Cross Country Healthcare, Inc. is engaged in providing healthcare recruiting, staffing, recruiting and workforce solutions. The company has market cap of $524.98 million. The Firm operates in three divisions: Nurse and Allied Staffing, Physician Staffing and Other Human Capital Management Services. It has a 107.92 P/E ratio. The Nurse and Allied Staffing segment provides traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, and branch local nurses and allied staffing.
Analysts expect China Pharma Holdings, Inc. (NYSEMKT:CPHI) to report $0.00 EPS on May, 16. About 53,177 shares traded. China Pharma Holdings, Inc. (NYSEMKT:CPHI) has risen 14.29% since September 26, 2016 and is uptrending. It has outperformed by 2.87% the S&P500.
China Pharma Holdings, Inc. is a holding company. The company has market cap of $10.03 million. The Firm conducts its production, marketing, finance, development and administrative activities through its subsidiary, Hainan Helpson Medical & Biotechnology Co., Ltd. in the People’s Republic of China (PRC). It currently has negative earnings. It is engaged in the development, manufacture and marketing of pharmaceutical products for human use in connection with various diseases and medical conditions in the PRC.
Ratings analysis reveals 80% of Cross Country Healthcare’s analysts are positive. Out of 5 Wall Street analysts rating Cross Country Healthcare, 4 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. The lowest target is $17 while the high is $20. The stock’s average target of $18.75 is 31.49% above today’s ($14.26) share price. CCRN was included in 7 notes of analysts from August 9, 2015. Benchmark initiated the stock with “Buy” rating in Friday, January 20 report. The firm earned “Buy” rating on Sunday, August 9 by Cantor Fitzgerald. On Wednesday, October 7 the stock rating was initiated by Lake Street with “Buy”. The firm earned “Buy” rating on Friday, November 6 by Cantor Fitzgerald. The firm earned “Buy” rating on Friday, March 11 by UBS. Avondale downgraded the stock to “Mkt Perform” rating in Tuesday, January 24 report.
Simcoe Capital Management Llc holds 4.26% of its portfolio in Cross Country Healthcare, Inc. for 555,705 shares. Skyline Asset Management Lp owns 1.77 million shares or 1.84% of their US portfolio. Moreover, Alphaone Investment Services Llc has 1.45% invested in the company for 334,506 shares. The Massachusetts-based Eagle Boston Investment Management Inc has invested 0.99% in the stock. Aristotle Capital Boston Llc, a Massachusetts-based fund reported 433,131 shares.
About 30,101 shares traded. Cross Country Healthcare, Inc. (NASDAQ:CCRN) has risen 20.42% since September 26, 2016 and is uptrending. It has outperformed by 9.00% the S&P500.
Since January 1, 0001, it had 0 insider buys, and 2 selling transactions for $681,981 activity.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.